Atlas Trials

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

Clinical trial NCT01986088 · COMPLETED

Trial details

NCT number
NCT01986088
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Migraine With or Without Aura
Start date
1996-11-01
Primary completion
1998-01-01
Enrollment
1008

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.